Editorial: Receptor biology and cell signaling in diabetes: volume II

Swayam Prakash Srivastava; Keizo Kanasaki

doi:10.3389/fphar.2023.1274914

Editorial: Receptor biology and cell signaling in diabetes: volume II

Front Pharmacol. 2023 Sep 13:14:1274914. doi: 10.3389/fphar.2023.1274914. eCollection 2023.

Authors

Swayam Prakash Srivastava¹, Keizo Kanasaki²

Affiliations

¹ Hartman Institute of Therapeutic Organ Regeneration, Division of Regenerative Medicine, Department of Medicine, Weill Cornell Medicine, New York, NY, United States.
² Internal Medicine 1, Shimane University Faculty of Medicine, Izumo, Japan.

No abstract available

Keywords: diabetes; diabetic kideny disease; endothelial cells; endothelial dysfuction; fibroblast growth factor receptor 1 (FGFR1); glucocorticoid receptor; receptor biology; sirtuin3 (sirt3).

Publication types

Editorial

Grants and funding

KK was supported by a grant from the Japan Society for the Promotion of Science (22K08330), and a grant from The Ministry of Health, Labour and Welfare (202112004A), Japan. KK has a consulting agreement with Boehringer Ingelheim. KK has collaborated with Boehringer Ingelheim, Taisho Pharma, and Kowa on a project not related to this manuscript. Shimane University was supported by funds from Boehringer Ingelheim, Mitsubishi Tanabe Pharma, Taisho Pharmaceutical, Ono Pharmaceutical, Kowa, Nipro, and Life Scan Japan.